Literature DB >> 28259503

Radiation Exposure of Patients and Interventional Radiologists during Prostatic Artery Embolization: A Prospective Single-Operator Study.

Gustavo Andrade1, Helen J Khoury2, William J Garzón2, Felipe Dubourcq3, Michel F Bredow3, Lucas M Monsignore4, Daniel G Abud4.   

Abstract

PURPOSE: To prospectively analyze the radiation exposure of patients and interventional radiologists during prostatic artery embolization (PAE).
MATERIALS AND METHODS: Twenty-five consecutive PAE procedures performed with an Artis zee system in a single center by an interventional radiologist were prospectively monitored. The mean age, weight, and prostate volume of the patients were 65.7 year (range, 43-85 y), 71.4 kg (range, 54-88 kg), and 79 cm3 (range, 36-157 cm3), respectively. In addition to Digital Imaging and Communications in Medicine radiation data, direct measures were also obtained. Radiochromic film was used to evaluate peak skin dose (PSD). The radiologist wore a protective apron and a thyroid collar, and a ceiling-suspended screen and a table curtain were used. To estimate the absorbed doses, nine pairs of dosimeters were attached to the operator's body.
RESULTS: The average fluoroscopy time was 30.9 minutes (range, 15.5-48.3 min). The mean total dose-area product (DAP) was 450.7 Gy·cm2 (range, 248.3-791.73 Gy·cm2) per procedure. Digital subtraction angiography was responsible for 71.5% of the total DAP, followed by fluoroscopy and cone-beam computed tomography. The mean PSD was 2,420.3 mGy (range, 1,390-3,616 mGy). The average effective dose for the interventional radiologist was 17 μSv (range, 4-47 μSv); values for the eyes, hands, and feet were obtained, and were all greater on the left side.
CONCLUSIONS: PAE may lead to high x-ray exposures to patients and interventional radiologists.
Copyright © 2017 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28259503     DOI: 10.1016/j.jvir.2017.01.005

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  10 in total

1.  Pitfalls in interventional X-ray organ dose assessment-combined experimental and computational phantom study: application to prostatic artery embolization.

Authors:  Philipp Roser; Annette Birkhold; Xia Zhong; Philipp Ochs; Elizaveta Stepina; Markus Kowarschik; Rebecca Fahrig; Andreas Maier
Journal:  Int J Comput Assist Radiol Surg       Date:  2019-08-03       Impact factor: 2.924

Review 2.  Efficacy and safety of prostatic artery embolization for benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Peng Xiang; Di Guan; Zhen Du; Yongxiu Hao; Wei Yan; Yonghui Wang; Yutong Liu; Dan Liu; Hao Ping
Journal:  Eur Radiol       Date:  2021-01-15       Impact factor: 5.315

Review 3.  Prostatic artery embolization for benign prostatic obstruction: assessment of safety and efficacy.

Authors:  Daniel Christidis; E Clarebrough; V Ly; M Perera; H Woo; N Lawrentschuk; D Bolton
Journal:  World J Urol       Date:  2018-02-14       Impact factor: 4.226

4.  Prostatic Artery Embolization: Indications, Preparation, Techniques, Imaging Evaluation, Reporting, and Complications.

Authors:  Ubenicio Silveira Dias; Maurício Ruettimann Liberato de Moura; Publio Cesar Cavalcante Viana; André Moreira de Assis; Antônio Sérgio Zanfred Marcelino; Airton Mota Moreira; Claudia Costa Leite; Giovanni Guido Cerri; Francisco Cesar Carnevale; Natally Horvat
Journal:  Radiographics       Date:  2021-08-20       Impact factor: 6.312

5.  Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial.

Authors:  Dominik Abt; Lukas Hechelhammer; Gautier Müllhaupt; Stefan Markart; Sabine Güsewell; Thomas M Kessler; Hans-Peter Schmid; Daniel S Engeler; Livio Mordasini
Journal:  BMJ       Date:  2018-06-19

Review 6.  Modern imaging and image-guided treatments of the prostate gland: MR and ablation for cancer and prostatic artery embolization for benign prostatic hyperplasia.

Authors:  João Lopes Dias; Tiago Bilhim
Journal:  BJR Open       Date:  2019-08-14

7.  An Updated Meta-Analysis of the Efficacy and Safety of Prostatic Artery Embolization vs. Transurethral Resection of the Prostate in the Treatment of Benign Prostatic Hyperplasia.

Authors:  Zhunan Xu; Zhongbao Zhou; Yingmei Mu; Tong Cai; Zhenli Gao; Lingling Liu
Journal:  Front Surg       Date:  2021-12-15

8.  Prostatic Artery Embolization for Benign Prostatic Hyperplasia: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2021-06-04

9.  Prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam CT to evaluate planning and treatment response.

Authors:  Marco Pandolfi; Alessandro Liguori; Martina Gurgitano; Antonio Arrichiello; Letizia Di Meglio; Giovanni Maria Rodà; Alice Guadagni; Salvatore Alessio Angileri; Anna Maria Ierardi; Giorgio Buccimazza; Daniela Donat; Aldo Paolucci; Gianpaolo Carrafiello
Journal:  Acta Biomed       Date:  2020-09-23

10.  Advanced image guidance for prostatic artery embolization - a multicenter technical note.

Authors:  Francisco Cesar Carnevale; Timothy McClure; Farah Cadour; Vincent Vidal; André Moreira de Assis; Airton Mota Moreira; Arthur Diego Dias Rocha; Aya Rebet; Charles Nutting
Journal:  CVIR Endovasc       Date:  2021-08-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.